a developer of transcription factors in the regulation of genes
Industry Biotechnology
A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with XNCR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then XNCR could also see price increases.
Ticker / NAME | Correlation To SGMO | 1D Price Change % | ||
---|---|---|---|---|
SGMO | 100% | -11.89% | ||
XNCR - SGMO | 40% Loosely correlated | -0.47% | ||
ZYME - SGMO | 34% Loosely correlated | -5.52% | ||
GLUE - SGMO | 33% Poorly correlated | -1.74% | ||
CRSP - SGMO | 32% Poorly correlated | -5.90% | ||
PGEN - SGMO | 32% Poorly correlated | -3.58% | ||
More |
Ticker / NAME | Correlation To SGMO | 1D Price Change % |
---|---|---|
SGMO | 100% | -11.89% |
drugs theme (254 stocks) | 34% Loosely correlated | -1.67% |
stem cells theme (21 stocks) | 28% Poorly correlated | -3.36% |
genes theme (4 stocks) | 23% Poorly correlated | -3.61% |
gene therapy theme (12 stocks) | 21% Poorly correlated | -4.25% |
biotechnology theme (238 stocks) | 18% Poorly correlated | -1.76% |
More |